Researchers looked at several studies and found a link between opioid use and C. diff infection. In the combined data, about 31% of patients who were taking opioids developed C. diff, compared with 17% of patients not using opioids.
C. diff causes severe diarrhea, nausea and vomiting. Opioids may raise risk because they can weaken the immune system and change the balance of bacteria in the gut.
The researchers say doctors should decide on opioids case by case. Healthy young people may have lower risk, but hospitalized or immunocompromised patients are at higher risk.
Difficult words
- opioid — a strong pain medicine, often addictiveopioid use, opioids
- infection — when germs enter and cause illness in body
- develop — to start to have or show a conditiondeveloped
- diarrhea — frequent, loose, watery bowel movements
- immune system — part of the body that fights infections
- immunocompromised — have a weaker than normal immune system
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you talk with a doctor about C. diff risk before using opioids? Why or why not?
- What should doctors think about when they decide to give opioids to a patient?
- How might care be different for hospitalized or immunocompromised patients?
Related articles
Study: Year‑round RSV Immunization Could Reduce Big Outbreaks
A study in Science Advances finds that offering RSV immunizations year‑round would lower the chance of large seasonal outbreaks in the United States. Researchers compared spread in cities and rural areas and tested seasonal versus year‑round schedules.
Virtual diet and exercise program helps people with lymphoma
A study tested a virtual diet and exercise program for people getting chemotherapy for lymphoma. The program improved symptoms, attendance was high, and participants had better strength and physical performance during treatment.
Rwanda strengthens response to Rift Valley Fever outbreak
Rwanda reported a second Rift Valley Fever outbreak near the Tanzania border and has increased surveillance and livestock vaccination. Officials say lack of rapid diagnostic tests slows detection, while a human vaccine candidate enters Phase II trials.